Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis.
CD24 gene allele variation is not associated with oligoclonal IgG bands and IgG index of multiple sclerosis patients.
Association of serum bilirubin and uric acid levels changes during neuroinflammation in patients with initial and relapsed demyelization attacks.
False positivity of anti aquaporin-4 antibodies in natalizumab-treated patients.
Validity of The Timed Up and Go as A Measure of Functional Mobility in Persons with Multiple Sclerosis.
Access to Multiple Sclerosis Specialty Care.
Enlargement of cerebral ventricles as an early indicator of encephalomyelitis.
The immunoproteasome: a novel drug target for autoimmune diseases.
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1a therapy in relapsing-remitting multiple sclerosis (the ARIANNA study).
Peripheral blood non-MAIT CD8+CD161hi cells are decreased in relapsing-remitting multiple sclerosis patients treated with interferon beta.
Behavioral and monoamine perturbations in adult male mice with chronic inflammation induced by repeated peripheral lipopolysaccharide administration.
No evidence of human herpesvirus DNA in the CSF of multiple sclerosis patients.
Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: patient preference and adherence.
Conclusion: National incidence and risk factor assessments may become a basis for the evaluation of prevention trials - prospects from the Third Nordic MS Symposium.
Transverse myelitis and bilateral optic neuritis in a patient with systemic lupus erythematosus.
Neurosarcoidosis: Clinical manifestations, diagnosis and treatment.
Erratum to: 'Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial'.
A 12-month prospective, observational study evaluating the impact of disease-modifying treatment on emotional burden in recently-diagnosed multiple sclerosis patients: The POSIDONIA study.
Prevalence of neurofascin-155 antibodies in patients with multiple sclerosis.
The glutathione S-transferase T1 deletion is associated with susceptibility to multiple sclerosis.
Risk of Demyelinating Diseases in the Central Nervous System in Patients With Inflammatory Bowel Disease Treated With Tumor Necrosis Factor Inhibitors.
Auditory deficits in neurological disorders.
Duality of Antidepressants and Neuroprotectants.
Human mesenchymal stem cells target adhesion molecules and receptors involved in T cell extravasation.
Towards a predictive model for Guillain-Barré syndrome.

Pages